latest videos
Prospects for bringing cell-based therapies into clinical practice; CNS Disorders, Batten’s Disease, Spinal Cord Injury. Featuring Martin McGlynn, Irving Weissman, Stephen Huhn, Michael Fehlings, Aileen Anderson.
What is a cancer immunotherapy product? Are cancer vaccines preventive or therapeutic? Are we controlling or curing cancer? Will treatments be reimbursed? What is the economic rationale for cancer immunotherapy products? What are some of the promising products in the pipeline? Is immunotherapy now a reality in the treatment of cancer?
How does the Tel-Aviv Stock Exchange (TASE) compare to the NASDAQ, AMEX, and other U.S. exchanges? What is the rationale for U.S. biomed investors to look at TASE-listed companies?
Eric J. Hall, CEO, and Bert Brodsky, Chairman of the Alzheimer’s Foundation of America, discuss hope for a cure, participation in clinical trials, diagnostics, and the socio-economic impact of the disease.
Following the success of a conference organized by BioBusiness.TV and MD Becker Partners on Oct 21st 2010, we are please to bring you the presentations of participating companies.
Featuring : David L. Urdal, PhD, Chief Scientific Officer, Dendreon
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
Featuring : Reiner Laus, M.D., EVP and President, Cancer Vaccines, Bavarian Nordic, and CEO & President, BN ImmunoTherapeutics.
This corporate presentation was recorded during “Cancer Immunotherapy: A Long Awaited Reality”, a conference hosted by BioBusiness.TV and MD Becker Partners on October 21st, 2010, at the New York Academy of Medicine.
BEST OF THE WEB by BioBusiness.TV
BioBusiness.TV presents the best videos on the web, for biotech professionals and aficionados.